VAV2 and cancer: In doing so, we further uncover the signalling mechanisms driving EphA-mediated cell–cell repulsion and find that signalling from EphA receptors, via the guanine nucleotide exchange factor (GEF) Vav2 to activate RhoA, can stimulate cancer cell–cell repulsion.